Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories -- Parion has a plan for the first clinical...
Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology PR Newswire SAN DIEGO and OSAKA, Japan, March 4, 2014 SAN DIEGO and OSAKA, Japan, March...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2565 | -2.49029126214 | 10.3 | 10.615 | 9.25 | 20384 | 10.00499221 | DR |
4 | -1.2815 | -11.3156732892 | 11.325 | 12.15 | 9.25 | 19783 | 10.29561269 | DR |
12 | -2.3565 | -19.0040322581 | 12.4 | 12.95 | 9.25 | 9476 | 10.52611456 | DR |
26 | -0.3465 | -3.33493743985 | 10.39 | 13 | 9.25 | 10009 | 11.21312592 | DR |
52 | 0.3165 | 3.25382954662 | 9.727 | 13 | 8.95 | 7533 | 10.86987745 | DR |
156 | -2.2365 | -18.2125407166 | 12.28 | 13 | 6.2 | 28253 | 9.18423151 | DR |
260 | -8.6265 | -46.2051419389 | 18.67 | 20.93 | 6.2 | 32915 | 12.05980232 | DR |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales